1. Abels RI (1992) Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer. Semin Oncol 19 [Suppl 8]: 29–35
2. Adamson JW, Schuster M, Allen S, Haley NR (1992) Effectiveness of recombinant human erythropoietin therapy in myelodysplastic syndromes. Acta Haematol 87 [Suppl 1]: 20–24
3. Afzali B, Goldsmith DJ (2004) Intravenous iron therapy in renal failure: friend and foe? J Nephrol 17: 487–495
4. Agarwal R, Warnock D (2002) Issues related to iron replacement in chronic kidney disease. Semin Nephrol 22: 479–487
5. Aggarwal HK, Nand N, Singh S, Singh M, Hemant, Kaushik G (2003) Comparison of oral versus intravenous iron therapy in predialysis patients of chronic renal failure receiving recombinant human erythropoietin. J Assoc Physicians India 51: 170–174